iHope Network

Donating clinical whole genome sequencing tests (cWGS) to help find answers for underserved families with children facing rare and undiagnosed diseases

大乐透怎么算中奖:iHope

超级大乐透中奖规则 www.slf2t.cn Clinical whole-genome sequencing is intended to provide information to physicians to aid in the diagnosis of inherited diseases, and to try to identify the underlying cause of a genetic condition. This test is most appropriate for situations where the evaluation of multiple genes may clarify or refine the diagnosis, a situation that can occur when the presenting set of symptoms and tests are inconclusive, there are many candidate genes to evaluate, or physicians believe that the patient may have multiple genetic conditions.

Through whole-genome sequencing, the iHope Network and their respective clinical partners strive to end years-long diagnostic odysseys. These odysseys average seven years in length and include multiple inconclusive tests, surgeries and procedures, many of which do not result in answers or treatment options for these children and their families.

“Understanding the scope and size of the population affected by rare diseases, we have a moral imperative to increase the visibility of this global health problem and help find solutions for the children and families who are suffering.”

Francis deSouza
Illumina President and CEO

The iHope Network members have committed to a minimum philanthropic donation of 10 whole genome tests per year (10 patients). Additionally, iHope Network organizations have agreed to donate the variants identified through iHope to public databases, like Clinvar, which are freely accessible, public archives of reports of the relationships among human variations and their related symptoms or diseases. By doing so, the public wealth of knowledge will continue to grow and provide benefit to many more patients who depend on the precision of genomic medicine.

With precision medicine and large-scale genomic initiatives being launched across the globe, genomics is reaching an inflection point in public awareness. The iHope program aims to build on that public awareness by demonstrating how next-generation sequencing can create a significant impact – by helping undiagnosed patients and their families find long sought-after answers.

Illumina
Genome One
Hudson Alpha
GeneDx
  • Foundation for the Children of the Californias
  • Lebonheur Children’s Hospital
  • Rare Genomics Institute
  • UCSF Benioff Children’s Hospital San Francisco
  • The Vision of Children Foundation
  • Washington University

Please contact Julia Ortega McEachern, PA, MHS, Research and Program Collaborations at Illumina at [email protected] with any questions.

View Press Release
Access FAQ PDF

  • 肝脏-热门标签-华商生活 2019-05-22
  • 苏宁控股集团获第十二届人民企业社会责任奖年度企业奖 2019-05-19
  • 上海:高校课程思政领航计划启动 2019-05-19
  • 江报直播室:两会谈“新”录 2019-05-07
  • 哪个不在痛打落水狗呢 2019-05-07
  • “中国网事·感动2017” 年度网络人物评选专家评审会在京召开 2019-05-01
  • 这家央企的员工为何这么拼? 2019-05-01
  • 自治区党委召开常委(扩大)会议 陈全国主持 2019-04-12
  • 新时代的主要矛盾是需要与发展不充分不平衡的矛盾,发展不充分的原因在于历史的欠账,近代的落后,发展的不平衡的原因应该归功于市场经济。 2019-04-12
  • 承认私有制存在,却否认阶级分析。睁着眼睛说瞎话,强坛独一份。 2019-04-02
  • 回复@老老保老张工:你肯定有咱无法企及的本事!比如你可以不要脸,咱就不行。 2019-04-01
  • 违法和不良信息举报受理和处置管理办法 2019-04-01
  • 人民日报开放谈:服务开放好处多 2019-03-31
  • 介休“厕所革命”助力美丽乡村建设 2019-03-31
  • 湖州地税全面实施“征前减免” 2019-03-09
  • 831| 737| 747| 314| 482| 536| 64| 375| 82| 911|